Company
Neurescue
The First and Only Treatment Approved for Non-Shockable Cardiac Arrest
Also known as Neurescue ApS
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Copenhagen, Denmark
- Legal name
- Neurescue ApS
Claim, correct or request removal
Record updated 18 September 2026
About
Neurescue develops medical devices to improve outcomes for emergency patients. Our flagship product, the NEURESCUE device, is the first approved for the treatment of non-shockable cardiac arrest. Our fluoroscopy-free balloon procedure supercharges blood flow to the heart & brain, which can directly achieve a regained heartbeat or conversion to a shockable rhythm, either of which can bridge the patient to recovery.
Products
- Hardware
- NEURESCUE device
Loading relationship preview